The team in Dresden is researching genetic engineering to combat hereditary diseases, 3D-printed tissues as a substitute for donor transplants, programmable stem cells that transform into complex 3D tissues, and living sensors. The aim is to gain understanding and control over biology as well as its implications for the future of healthcare.
The hub is currently focusing on organoids for pharmaceutical research and personalized, regenerative medicine.